Celexa Birth Defects

Multiple studies have found that children born to women who use Celexa while pregnant face an increased risk of developing congenital heart defects or other birth defects.

A 2007 study published by the New England Journal of Medicine found that children born to pregnant women who took the antidepressant Celexa were three times more likely to suffer right ventricular defects than women who did not take the drug.

A second study published in 2007 reported that women using Celexa while pregnant were more than twice as likely to give birth to a child with anencephaly (large part of the brain or skull missing), craniosynostosis (early fusion of the sutures of the skull) or omphalocele (abdominal organs protrude into the umbilical cord).

Studies show that babies exposed to antidepressants such as Celexa in the last trimester of pregnancy are six times more likely to be born with persistent pulmonary hypertension of the newborn (PPHN) than babies who were not exposed to the drug. PPHN is a serious and potentially fatal circulatory condition that makes it difficult for oxygen to reach the blood stream. PPHN can cause developmental disabilities, heart failure, kidney failure, organ damage, seizures, or death.

Children born to Celexa users may also be at increased risk for other birth defects, including:

• Austism Spectrum Disorder

• Cleft Lip

• Cleft Palate

• Anal Atresia

• Pulmanary Stenosis

• Club Foot

I am currently represented by an attorney
*Required fields